Moreover, women are more likely to present with interval CRC (i.e. CRC diagnosed in the interval between screening episodes after a ‘negative’ screening test result),5,6 indicating that the f-Hb concentration is less diagnostically sensitive in women than in men. This evidence concerns the gene GSTM1 and colorectal carcinoma.